Ophthalmology And Therapy

杂志介绍

Ophthalmology And Therapy杂志介绍

《Ophthalmology And Therapy》是一本以English为主的开放获取国际优秀期刊，中文名称眼科和治疗，本刊主要出版、报道医学-OPHTHALMOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.6，最新CiteScore 指数为4.2。

本刊近期中国学者发表的论文主要有：

• Nonsurgical Management of Severe Viral Keratitis with Hypopyon and Retrocorneal Plaques: A Case Series

  Author: Yang, Zhen; Yu, Shuo; Zhang, Chun; Agrawal, Rupesh; Feng, Yun

• The Double-Deck Viscoelastic Technique: a Novel Surgical Technique to Protect the Corneal Endothelium in Penetrating Keratoplasty of Aphakic Silicone Oil-Dependent Eyes after Severe Ocular Injury

  Author: Cen, Yujie; Zhang, Mingzhou; Lu, Yao; Feng, Yun

• Determination of Vascular Endothelial Growth Factor-B Concentrations in Aqueous Humor and Plasma of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients Before and After Anti-VEGF Therapy

  Author: Zhou, Huiying; Zhao, Xinyu; Wang, Shuran; Chen, Youxin

• Clinical Feasibility and Safety of Scleral Collagen Cross-Linking by Riboflavin and Ultraviolet A in Pathological Myopia Blindness: A Pilot Study

  Author: Li, Yu; Qi, Yue; Sun, Mingshen; Zhai, Changbin; Wei, Wenbin; Zhang, Fengju

英文介绍

Ophthalmology And Therapy杂志英文介绍

Ophthalmology And Therapy is an open access, peer-reviewed (single-blind), fast-publishing international journal. The scope of the journal is broad and will consider all scientifically sound research, from preclinical, clinical (all stages), observational, real-world and health outcome studies, around the use of ophthalmic therapies, devices and surgical techniques.

The journal is of interest to a broad range of pharmaceutical and healthcare professionals and publishes short newsletters such as original studies, reviews, case reports/series, trial protocols, and reviews and editorials. Ophthalmology and treatment will consider all scientifically sound studies, whether positive, confirmed or negative data. Submissions are welcome regardless of whether they reach an international and/or country-specific audience, which is crucial when researchers are trying to target more specific patient groups. This inclusive approach allows the journal to assist in disseminating high-quality research, which may be considered of insufficient interest by other journals.